Morepen Laboratories submits first U.S. ANDA for sitagliptin tablets USP in three strengths
The filing covers three strengths of sitagliptin tablets USP.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Morepen Laboratories Submits First U.S. ANDA For Sitagliptin Tablets USP In Three Strengths
Morepen Laboratories Ltd NSE:MOREPENLAB